Cargando…
Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia
Objective. To determine the second-trimester amniotic fluid concentrations of complement split products in pregnancies subsequently affected by early-onset preeclampsia. Study Design. Cohort of 731 women with singleton pregnancies undergoing second-trimester genetic amniocentesis followed up to deli...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628677/ https://www.ncbi.nlm.nih.gov/pubmed/26556948 http://dx.doi.org/10.1155/2015/263109 |
_version_ | 1782398468797497344 |
---|---|
author | Banadakoppa, Manu Vidaeff, Alex C. Yallampalli, Uma Ramin, Susan M. Belfort, Michael A. Yallampalli, Chandra |
author_facet | Banadakoppa, Manu Vidaeff, Alex C. Yallampalli, Uma Ramin, Susan M. Belfort, Michael A. Yallampalli, Chandra |
author_sort | Banadakoppa, Manu |
collection | PubMed |
description | Objective. To determine the second-trimester amniotic fluid concentrations of complement split products in pregnancies subsequently affected by early-onset preeclampsia. Study Design. Cohort of 731 women with singleton pregnancies undergoing second-trimester genetic amniocentesis followed up to delivery and analyzed as a nested case-control study. Cases of preeclampsia developing before 34 weeks' gestation (n = 15) were compared with 47 uncomplicated term controls. Amniotic fluid collected at amniocentesis was tested for complement split products Bb, C4a, C3a, and C5a. Results. Women who developed early-onset preeclampsia as compared with the term pregnant controls had significantly higher (P = 0.04) median amniotic fluid C3a levels (318.7 ng/mL versus 254.5 ng/mL). Median amniotic fluid Bb levels were also significantly higher (P = 0.03) in preeclamptic women than in normal pregnant women (1127 ng/mL versus 749 ng/mL). Median levels of C4a and C5a were not significantly different between the groups. Conclusion. Our data suggest that complement activation in early pregnancy is associated with early-onset preeclampsia. We believe this to be the first prospective study to link complement activation in amniotic fluid in early pregnancy and later development of preeclampsia. Our findings provide evidence that immune dysregulation may precede the clinical manifestations of preeclampsia and that the alternative complement pathway is principally involved. |
format | Online Article Text |
id | pubmed-4628677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46286772015-11-09 Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia Banadakoppa, Manu Vidaeff, Alex C. Yallampalli, Uma Ramin, Susan M. Belfort, Michael A. Yallampalli, Chandra Dis Markers Research Article Objective. To determine the second-trimester amniotic fluid concentrations of complement split products in pregnancies subsequently affected by early-onset preeclampsia. Study Design. Cohort of 731 women with singleton pregnancies undergoing second-trimester genetic amniocentesis followed up to delivery and analyzed as a nested case-control study. Cases of preeclampsia developing before 34 weeks' gestation (n = 15) were compared with 47 uncomplicated term controls. Amniotic fluid collected at amniocentesis was tested for complement split products Bb, C4a, C3a, and C5a. Results. Women who developed early-onset preeclampsia as compared with the term pregnant controls had significantly higher (P = 0.04) median amniotic fluid C3a levels (318.7 ng/mL versus 254.5 ng/mL). Median amniotic fluid Bb levels were also significantly higher (P = 0.03) in preeclamptic women than in normal pregnant women (1127 ng/mL versus 749 ng/mL). Median levels of C4a and C5a were not significantly different between the groups. Conclusion. Our data suggest that complement activation in early pregnancy is associated with early-onset preeclampsia. We believe this to be the first prospective study to link complement activation in amniotic fluid in early pregnancy and later development of preeclampsia. Our findings provide evidence that immune dysregulation may precede the clinical manifestations of preeclampsia and that the alternative complement pathway is principally involved. Hindawi Publishing Corporation 2015 2015-10-18 /pmc/articles/PMC4628677/ /pubmed/26556948 http://dx.doi.org/10.1155/2015/263109 Text en Copyright © 2015 Manu Banadakoppa et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Banadakoppa, Manu Vidaeff, Alex C. Yallampalli, Uma Ramin, Susan M. Belfort, Michael A. Yallampalli, Chandra Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia |
title | Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia |
title_full | Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia |
title_fullStr | Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia |
title_full_unstemmed | Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia |
title_short | Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia |
title_sort | complement split products in amniotic fluid in pregnancies subsequently developing early-onset preeclampsia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628677/ https://www.ncbi.nlm.nih.gov/pubmed/26556948 http://dx.doi.org/10.1155/2015/263109 |
work_keys_str_mv | AT banadakoppamanu complementsplitproductsinamnioticfluidinpregnanciessubsequentlydevelopingearlyonsetpreeclampsia AT vidaeffalexc complementsplitproductsinamnioticfluidinpregnanciessubsequentlydevelopingearlyonsetpreeclampsia AT yallampalliuma complementsplitproductsinamnioticfluidinpregnanciessubsequentlydevelopingearlyonsetpreeclampsia AT raminsusanm complementsplitproductsinamnioticfluidinpregnanciessubsequentlydevelopingearlyonsetpreeclampsia AT belfortmichaela complementsplitproductsinamnioticfluidinpregnanciessubsequentlydevelopingearlyonsetpreeclampsia AT yallampallichandra complementsplitproductsinamnioticfluidinpregnanciessubsequentlydevelopingearlyonsetpreeclampsia |